Loading
Latest filing published 31 Jul 2019 for Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.).
No signal scores available.
All filings by Lumira Capital Investment Management Inc. on record concern Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.). The record holds 6 filings, for trades running from 7 June 2019 to 26 July 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 31 July 2019, reports a transaction in Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 13 days. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations